SCHEMBL3869422

SCHEMBL3869422

c1ccc(N(c2ccccc2)c2ccc3c(c2)C(c2ccccc2)(c2ccccc2)c2cc(N(c4ccccc4)c4ccccc4)ccc2-3)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ PDK2 Q15119 3/20 0.38
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ OPRK1 P41145 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ CRHBP P24387 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ CRHR2 Q13324 1/20 0.35
▸ TLR9 Q9NR96 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12439941 0.96 KDM4E (0.42) KDM4EMAPTALDH1A1L3MBTL1CYP1A2
SCHEMBL16996106 0.95 MEN1 (0.44) KDM4EMAPTALDH1A1L3MBTL1CYP1A2
SCHEMBL15213745 0.95 MEN1 (0.44) KDM4EMAPTALDH1A1L3MBTL1CYP1A2
SCHEMBL17903055 0.93 MEN1 (0.47) KDM4EMAPTALDH1A1L3MBTL1CYP1A2
SCHEMBL10038930 0.93 MEN1 (0.43) KDM4EMAPTALDH1A1L3MBTL1CYP1A2
SCHEMBL25563179 0.93 MEN1 (0.43) KDM4EMAPTALDH1A1L3MBTL1CYP1A2
SCHEMBL13137305 0.93 MAPT (0.36) KDM4EMAPTALDH1A1L3MBTL1CYP1A2
SCHEMBL21587217 0.93 MAPT (0.36) KDM4EMAPTALDH1A1L3MBTL1CYP1A2
SCHEMBL15866674 0.93 MEN1 (0.47) KDM4EMAPTALDH1A1L3MBTL1CYP1A2
SCHEMBL18079831 0.93 ALDH1A1 (0.38) KDM4EMAPTALDH1A1L3MBTL1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210336144-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2021-10-28 — — US disclosed
US-11018304-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2021-05-25 — — US disclosed
US-20200259086-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2020-08-13 — — US disclosed
EP-3579292-B1 ORGANIC LIGHT EMITTING DEVICE LG CHEMICAL LTD (KR) 2020-08-05 — — EP disclosed
US-10665789-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2020-05-26 — — US disclosed
EP-3579292-A1 ORGANIC LIGHT EMITTING DEVICE LG Chem, Ltd. (KR) 2019-12-11 — — EP disclosed
US-9896621-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2018-02-20 — — US disclosed
US-9896621-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2018-02-20 — — US disclosed
EP-2978040-B1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO LTD (KR) 2017-12-27 — — EP disclosed
US-20170155050-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-01 — — US disclosed
US-20160028014-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2016-01-28 — — US disclosed
EP-2978040-A1 ORGANIC LIGHT-EMITTING DEVICE Samsung Display Co., Ltd. (KR) 2016-01-27 — — EP disclosed
US-7799440-B2 Organic electroluminescent device and host material of luminescent and hole-blocking material thereof CHI MEI OPTOELECTRONICS CORP. (TW) 2010-09-21 — — US disclosed
US-7799440-B2 Organic electroluminescent device and host material of luminescent and hole-blocking material thereof CHI MEI OPTOELECTRONICS CORP. (TW) 2010-09-21 — — US disclosed
WO-2009082157-A2 ARYL AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME DOOSAN CORPORATION (KR) 2009-07-02 — — WO disclosed
US-7482490-B2 Amine compound having fluorene group as framework, process for producing the amine compound, and use of the amine compound TOSOH CORPORATION (JP) 2009-01-27 — — US disclosed
US-20080194878-A1 Amine Compound Having Fluorene Group as Framework, Process for Producing the Amine Compound, and Use of the Amine Compound TOSOH CORPORATION (JP) 2008-08-14 — — US disclosed
EP-1752440-A1 AMINE COMPOUND HAVING FLUORENE GROUP AS FRAMEWORK, PROCESS FOR PRODUCING THE AMINE COMPOUND, AND USE OF THE AMINE COMPOUND Tosoh Corporation (JP) 2007-02-14 — — EP disclosed
US-20070015005-A1 Organic electroluminescent device and host material of luminescent and hole-blocking material thereof CHI MEI OPTOELECTRONICS CORP. (TW) 2007-01-18 — — US disclosed
US-20070015005-A1 Organic electroluminescent device and host material of luminescent and hole-blocking material thereof CHI MEI OPTOELECTRONICS CORP. (TW) 2007-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194878-A1 Amine Compound Having Fluorene Group as Framework, Process for Producing the Amine Compound, and Use of the Amine Compound TAAR1, SLC18A1, ADRB2 KDM4E 3513/4885MAPT 4140/4885ALDH1A1 1351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback